Elissa Townsend
Nurse Practitioner · Vandalla, ILNPI 1598225344
Payments from drug & device makers
Across 75 payments — averaging $18.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$335
- Novo Nordisk$274
- Johnson & Johnson$113
- Boehringer Ingelheim$77
- Lundbeck LLC$75
- AstraZeneca$68
- plus $430 from 16 others
What the payments were for
- Food & beverage$1,371100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 20 | $335 |
| Novo Nordisk | 15 | $274 |
| Johnson & Johnson(2 entities) | 4 | $113 |
| Boehringer Ingelheim | 4 | $77 |
| Lundbeck LLC | 4 | $75 |
| AstraZeneca | 4 | $68 |
| Sanofi | 2 | $57 |
| Mylan Specialty L.p. | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Esperion Therapeutics, Inc. | 2 | $37 |
| AbbVie | 2 | $33 |
| Exact Sciences | 2 | $31 |
| Almatica Pharma LLC | 2 | $25 |
| Astellas Pharma US Inc | 1 | $25 |
| Biohaven Pharmaceuticals, Inc. | 2 | $25 |
| Optinose US, Inc. | 1 | $18 |
| Philips North America LLC | 1 | $17 |
| Vertex | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| GSK | 1 | $15 |
| Amgen | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
How this compares
$1,371 in reported general payments places this provider in the 85th percentile of 4,869 nurse practitioner providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 41 | $67,072 |
| EliquisApixaban | 37 | $45,850 |
| JardianceEmpagliflozin | 31 | $36,103 |
| OzempicSemaglutide | 13 | $22,504 |
| TrulicityDulaglutide | 14 | $13,907 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $11,387 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 270 | $4,561 |
| Fentanyl | 26 | $3,350 |
| Gabapentin | 93 | $3,228 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 64 | $2,324 |
| Hydroxychloroquine Sulfate | 47 | $2,006 |
| Potassium Chloride | 85 | $1,642 |
| Lorazepam | 303 | $1,528 |
| Lisinopril | 154 | $1,435 |
| Levothyroxine Sodium | 112 | $1,202 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $335 | $80,97955 claims |
| Boehringer IngelheimJardiance | $77 | $36,10331 claims |
| Novo NordiskOzempic | $274 | $22,50413 claims |
| GSKTrelegy Ellipta | $15 | $11,38714 claims |
| Almatica Pharma LLCSertraline Hcl | $25 | $69657 claims |
| AbbVieSynthroid | $33 | $64012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,869 nurse practitioner providers in Illinois.
Other nurse practitioner in Vandalla
- Erika VuckoChicago$417K
- Deepa VallikatWest Dundee$332K
- Maria MalotoNaperville$135K
- Valerie LaroyOak Lawn$112K
- Jennifer LiebChampaign$109K
- Tanya MungerRockford$106K
- Kristy LukeChicago$77K
- Yvonna OldakerFlossmoor$74K
- Heather PiercePekin$72K
- Dara McKinleyEvanston$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.